ERC-2018-COG
ERC-2018-COG
Programme: H2020
292 projects · €571,935,383 total EU contribution (project-level) · 216 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€571,935,383
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (38)
- Germany (34)
- Italy (21)
- Spain (18)
- Netherlands (15)
- France (14)
- AT (12)
- CH (10)
- BE (8)
- NO (8)
- EL (6)
- IE (5)
- IL (5)
- PT (5)
- SE (4)
- CA (3)
- DK (2)
- FI (2)
- US (2)
- CY (1)
- CZ (1)
- LU (1)
- ZA (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CNRS24 projects · FR
- UOXF12 projects · UK
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE11 projects · UK
- WEIZMANN11 projects · IL
- ETH Zürich10 projects · CH
- MPG9 projects · DE
- UNIVERSITY COLLEGE LONDON8 projects · UK
- AU6 projects · DK
- TAU6 projects · IL
- UZH6 projects · CH
- CEA5 projects · FR
- EPFL4 projects · CH
Projects
Page 18 of 30
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Novel Echoes. Ancient Novelistic Receptions and Concepts of Fiction in Late Antique and Medieval Secular Narrative from East to West NovelEchoes · 819459 | H2020 | €1,999,375 | €1,999,375 | Details |
Statistical Methods For High Dimensional Diffusions STAMFORD · 815703 | H2020 | €1,655,048 | €1,504,549 | Details |
Vibrating carbon nanotubes for probing quantum systems at the mesoscale MesoPhone · 818751 | H2020 | €2,748,271 | €2,748,271 | Details |
SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE SECRETE-HF · 818715 | H2020 | €1,999,861 | €432,748 | Details |
CORRECTING INEQUALITY THROUGH LAW: HOW COURTS CONCEPTUALIZE EQUALITY IN THEIR CONSTITUTIONAL JURISPRUDENCE EQUALITY · 817652 | H2020 | €1,606,597 | €1,606,597 | Details |
Novel mitochondria-targeted therapies for cancer treatment-induced cardiotoxicity MATRIX · 819775 | H2020 | €1,999,375 | €1,473,438 | Details |
South American population history revisited: multidisciplinary perspectives on the Upper Amazon SAPPHIRE · 818854 | H2020 | €1,993,378 | €1,993,378 | Details |
Repurposing small RNA from ciliates for genome editing: single-molecule study MIGHTY_RNA · 819299 | H2020 | €1,792,850 | €1,792,850 | Details |
3D integration of a logic/memory CUBE for In-Memory-Computing MY-CUBE · 820048 | H2020 | €2,734,139 | €2,734,139 | Details |
A unified drug discovery platform for protein misfolding diseases ProMiDis · 819934 | H2020 | €1,972,000 | €1,094,672 | Details |